In the BioHarmony Drug Report Database

"Preview" Icon

Carvedilol

Coreg (carvedilol) is a small molecule pharmaceutical. Carvedilol was first approved as Coreg on 1995-09-14. It is used to treat angina pectoris, heart failure, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-2 adrenergic receptor and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor and ryanodine receptor 2.

 

Trade Name

 

Coreg
 

Common Name

 

carvedilol
 

ChEMBL ID

 

CHEMBL723
 

Indication

 

angina pectoris, heart failure, hypertension, myocardial infarction
 

Drug Class

 

Vasodilators (undefined group)

Image (chem structure or protein)

Carvedilol structure rendering